Dietary support in hyperhomocysteinemia
, 1
Abstract
The study presents a case of a 70-year-old obese male with hyperhomocysteinemia, hypertension, abnormal glucose tolerance, and a history of stroke. Despite medication, his condition persisted due to dietary factors, including excessive salt, protein, and fat intake, and inadequate intake of vitamins B6 and folic acid. The intervention aimed to reduce homocysteine levels, achieve weight loss, improve metabolic health, and optimize nutrient intake. A reduction diet based on DASH and Mediterranean principles was implemented, emphasizing glycemic index/load education and nutrient-balanced meals. After 3 months, significant improvements were observed: weight loss (3.3 kg), reduced body fat percentage, improved body composition, and biochemical enhancements, including decreased homocysteine levels (3.1 μmol/L), increased plasma levels of vitamins B6, B12, and folic acid, and improved lipid profile and glucose levels. These positive outcomes were achieved solely through dietary changes, highlighting the efficacy of tailored dietary interventions in managing complex health conditions without additional pharmacological treatment. The study underscores the importance of personalized dietary strategies in holistic health management, emphasizing the potential for significant health improvements through targeted dietary modifications.
Keywords: case reportshyperhomocysteinemiaDASH diethypertensiondietary management
References
- Mutairi FAl. Hyperhomocysteinemia: Clinical Insights. Journal of Central Nervous System Disease. 2020; 12: 117957352096223.
- Kim J, Kim H, Roh H, et al. Causes of hyperhomocysteinemia and its pathological significance. Arch Pharm Res. 2018; 41(4): 372–383.
- Tsiami A, Obersby D. B Vitamins Intake and Plasma Homocysteine in Vegetarians. W: Vegetarian and Plant-Based Diets in Health and Disease Prevention [Internet]. Elsevier; 2017 [cytowane 8 kwiecień 2024]. s. 747–67. Dostępne na:. https://linkinghub.elsevier.com/retrieve/pii/B9780128039687000411.
- Rehman T, Shabbir MA, Inam-Ur-Raheem M, et al. Cysteine and homocysteine as biomarker of various diseases. Food Sci Nutr. 2020; 8(9): 4696–4707.
- Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004; 50(1): 3–32.
- Kaye AD, Jeha GM, Pham AD, et al. Folic acid supplementation in patients with elevated homocysteine levels. Adv Ther. 2020; 37(10): 4149–4164.
- Al Hageh C, Alefishat E, Ghassibe-Sabbagh M, et al. Homocysteine levels, H-Hypertension, and the MTHFR C677T genotypes: A complex interaction. Heliyon. 2023; 9(6): e16444.
- Zabrocka J, Wojszel ZB. Niedobór witaminy B12 w wieku podeszłym – przyczyny, następstwa, podejście terapeutyczne.
- Tinelli C, Di Pino A, Ficulle E, et al. Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Front Nutr. 2019; 6: 49.
- Wu X, Zhang L, Miao Y, et al. Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis. Redox Biol. 2019; 20: 46–59.
- Wei M, Wang Le, Liu YS, et al. Homocysteine as a potential predictive factor for high major adverse cardiovascular events risk in female patients with premature acute coronary syndrome. Medicine (Baltimore). 2019; 98(47): e18019.
- Guéant JL, Guéant-Rodriguez RM, Oussalah A, et al. Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials. Thromb Haemost. 2023; 123(3): 270–282.
- Hankey GJB. vitamins for stroke prevention. Stroke Vasc Neurol czerwiec. 2018; 3(2): 51–8.
- Kumar A, Palfrey HA, Pathak R, et al. The metabolism and significance of homocysteine in nutrition and health. Nutr Metab (Lond). 2017; 14: 78.
- Elango R. Methionine Nutrition and Metabolism: Insights from Animal Studies to Inform Human Nutrition. J Nutr. 2020; 150(Suppl 1): 2518S–2523S.
- Aledo JC. Methionine in proteins: The Cinderella of the proteinogenic amino acids. Protein Sci. 2019; 28(10): 1785–1796.